Cord Blood Center Group Released Two More Cord Blood Units for Life Saving Treatment
International transplant communities recognize Cord Blood Center Group as an important partner who helps physicians to treat patients by providing them with high quality cord blood for transplantation. In May 2011 two cord blood units released by CBC Group travelled long distances to patients in France and the U.S.
This is the case of the 16th and 17th cord blood graft processed by the Cord Blood Center Group experts, which were released to save a human life. Cord blood grafts were released from the public cord blood bank Eurocord-Slovakia, a member of the international Cord Blood Center Group.
One of the patients is 12 year old child suffering from acute leukemia. Another one is adult woman in her fifties treated for preleukemia syndrome. Both conditions require stem cell transplantation from a donor. The best matching donor was found in the public cord blood bank run by CBC Group.Patients will undergo allogenic hematopoietic stem cell transplantation. This means that their disease stricken and/or damaged stem cells in bone marrow will be destroyed and replaced by healthy stem cells from donor’s cord blood.
Nowadays autologous and allogenic cord blood transplantation is used in the treatment of over 80 serious diseases. What is more, autologous - child’s own cord blood is used in experimental treatment of type 1 diabetes, cerebral palsy and other traumatic brain damages.
The Cord Blood Center Group is one of the leading private cord blood banks offering services across Europe. Since 1999 the Cord Blood Center Group has been running its own processing and storage facilities. The Cord Blood Center Group enable parents to bank their child's cord blood in a family bank for future medical use or to donate it to a public bank. Donated cord blood is available for treatment of unrelated patients worldwide through international cooperation. The Cord Blood Center Group has released cord blood unit for the 1st autologous cord blood transplantation in Europe for a baby boy suffering medulloblastoma.
Back to Press News